Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer

On successful completion of this activity one should be able to judge the prognosis of patients harboring metastasized differentiated thyroid cancer (DTC); identify suitable treatment regimens, taking into account the characteristics of the tumor and the patient's general condition; and know th...

Full description

Saved in:
Bibliographic Details
Published inJournal of Nuclear Medicine Vol. 60; no. 1; pp. 9 - 15
Main Authors Kreissl, Michael C, Janssen, Marcel J R, Nagarajah, James
Format Journal Article
LanguageEnglish
Published United States Society of Nuclear Medicine 01.01.2019
Subjects
Cancer
Iodine 131
Iodine radioisotopes
Medical prognosis
Medical treatment
Metastasis
Patients
Protein-tyrosine kinase
Thyroid
Thyroid cancer
Tumors
Tyrosine
metastasized thyroid cancer
tyrosine kinase inhibitor
redifferentiation
radioiodine refractory thyroid cancer
Online AccessGet full text

Cover

More Information
Summary:On successful completion of this activity one should be able to judge the prognosis of patients harboring metastasized differentiated thyroid cancer (DTC); identify suitable treatment regimens, taking into account the characteristics of the tumor and the patient's general condition; and know the basics of radioiodine treatment, tyrosine kinase treatment, and redifferentiation treatment for metastasized DTC.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0161-5505
1535-5667
2159-662X
DOI:10.2967/jnumed.117.190819